Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. McKay's primary interest is in type 2 diabetes in children. She is the Medical Director and the Principle Investigator for the Baylor site of TODAY (Treatment Options in Type 2 Diabetes in Adolescents and Youth). TODAY is an NIH-sponsored, multicenter trial that will determine which of three treatment options (metformin alone, metformin plus intensive lifestyle changes, and metformin plus rosiglitazone) best maintains glycemic control in children with type 2 diabetes. In other research endeavors, she is investigating the ethnic differences in co-morbidities in children with type 2 diabetes and the effect of exercise on fuel utilization children with type 2 diabetes. Dr. McKay is also a Co-Investigator on a study to see whether teaching parents problem-solving strategies can improve glycemic control in a child with type 1 diabetes.
Diabetes, childhood diabetes, type 1 diabetes, type 2 diabetes, Type 1 diabetes in children, Type 2 diabetes in children,Diabetes immunogenetics
Research Article: J Diabetes Metab 2013, 4:319